Mary O. Balogun, MBBS
Mary O. Balogun holds a MBBS degree from the University of Ibadan, Nigeria, a Master's degree in Public Health and is a fellow of the West African College of Physicians. She also has a Diploma in Occupational Medicine of the Faculty of Occupational Medicine, United Kingdom. She is a lecturer in the Occupational Health Unit, Department of Preventive Medicine and Primary Care, College of Medicine, University of Ibadan and a community physician consultant at the University College Hospital, Nigeria. Her areas of interst are in the field of occupational health, especially health and safety of workers in the informal sectors, women's health, and domestic violence. She is presently working on a proposal to assess health outcomes (DNA damage, genotoxicity) from exposure to volatile organic compounds in petrol station workers.
William Balogun, MBBS
William Balogun holds a MBBS and a Master’s of Science in Chemical Pathology from the University of Ibadan, Nigeria and has completed fellowships with the West African College of Physicians in Endocrinology. Currently, pursuing a PhD in the same department where he plans to bridge bench and bedside work, particularly in diabetes. His interests include diabetes prevention and slowing or halting progression of diabetes with the ultimate aim of preventing untoward micro- and macrovascular complications. William has conducted research exploring the risk factors for diabetes, the link between diabetes and renal function, relationship between liver enzymes, inflammatory markers and diabetes, as well as genetic work on diabetes among West African populations.
Imaria Agwai is a doctoral student in Epidemiology and holds a Master's of Public health from the University of Ibadan. Her research interest include HIV/AIDS, gedner based violence and hereditary breast cancer. Her current research aims to understand breast cancer risk and effect of genetic counselng and testing on screening practices among female relatives of breast cancer patients. This also involves genetic testing of consentig participants in order to determine the prevalence and spectra of BRCA1/2 and other newer mutation genes as well as genetic counseling uptake and acceptability among first and second-degree female relatives of breast cancer patients at the University College Hospital, Ibadan.
Toyin Aniagwu, MPH